Kimiko Ubukata
- Epidemiology top 1%
- Microbiology top 0.2%
- Infectious Diseases top 5%
- Public Health, Environmental and Occupational Health top 5%
- Molecular Medicine top 1%
- Co-authors
- Miyuki MorozumiSatoshi IwataNaoko ChibaTakashi TakahashiKeisuke SunakawaKeiko HasegawaSomay Yamagata MurayamaReiko Kobayashi
- Topics
- Pneumonia and Respiratory Infections (54 papers)Bacterial Infections and Vaccines (33 papers)Respiratory viral infections research (22 papers)
- Journals
- Clinical Infectious DiseasesJournal of Clinical MicrobiologyAntimicrobial Agents and Chemotherapy
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Kimiko Ubukata
81 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 84
- Epidemiology 1.9k
- Microbiology 1.2k
- Infectious Diseases 491
- Public Health, Environmental and Occupational Health 472
- Molecular Medicine 365
Countries citing papers authored by Kimiko Ubukata
This map shows the geographic impact of Kimiko Ubukata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimiko Ubukata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimiko Ubukata more than expected).
Fields of papers citing papers by Kimiko Ubukata
This network shows the impact of papers produced by Kimiko Ubukata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimiko Ubukata. The network helps show where Kimiko Ubukata may publish in the future.
Co-authorship network of co-authors of Kimiko Ubukata
This figure shows the co-authorship network connecting the top 25 collaborators of Kimiko Ubukata. A scholar is included among the top collaborators of Kimiko Ubukata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimiko Ubukata. Kimiko Ubukata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 16 | |
| 4 | 161 | |
| 5 | 9 | |
| 6 | 22 | |
| 7 | An open clinical study of tebipenem pivoxil in children with acute otitis media and acute upper respiratory tract infection (phase II) | 1 |
| 8 | Antibiotic susceptibility and resistance gene analysis of Haemophilus influenza in clinical tebipenem-pivoxil studies in pediatric patients using PCR method | 3 |
| 9 | A open clinical trial study of tebipenem pivoxil fine granule for treatment of pediatric patients with otorlaryngological infections | 1 |
| 10 | 21 | |
| 11 | 96 | |
| 12 | 33 | |
| 13 | 87 | |
| 14 | 25 | |
| 15 | 109 | |
| 16 | 6 | |
| 17 | Epidemiology of Streptococcus pneumoniae isolates from patients with meningitis between 1993 and 2002 | 2 |
| 18 | 2 | |
| 19 | Antibacterial activity of imipenem for enterococci and methicillin-resistant staphylococci | 1 |
| 20 | 2 |
About Kimiko Ubukata
Kimiko Ubukata is a scholar working on Microbiology, Molecular Medicine and Epidemiology, having authored 81 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (54 papers), Bacterial Infections and Vaccines (33 papers) and Respiratory viral infections research (22 papers). The work is most often cited by research in Microbiology (1.2k citations), Molecular Medicine (365 citations) and Epidemiology (1.9k citations). Kimiko Ubukata has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Miyuki Morozumi, Satoshi Iwata, Naoko Chiba, Takashi Takahashi, Keisuke Sunakawa, Keiko Hasegawa, Somay Yamagata Murayama, Reiko Kobayashi, Eiichi Nakayama and Takeshi Tajima. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.